resveratrol has been researched along with Constriction, Pathologic in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andersen, OS; Barbieri, KP; Bosquesi, PL; Carlos, IZ; Chelucci, RC; Costa, FF; de Souza, CM; Dos Santos, JL; Fernandes, GFDS; Lanaro, C; Melchior, ACB; Pavan, AR; Rusinova, R | 1 |
| Bagriyanik, HA; Cetinkaya, C; Ersoy, N; Ikizoglu, E; Kamanga, LG; Kiray, M; Kutri, D; Ozcana, T | 1 |
| Cui, WG; Wang, C; Xu, Y; Ye, F; Yu, C; Zhang, JF; Zhao, X; Zhou, WH | 1 |
| Dugas, TR; Foley, JD; Kleinedler, JJ; Orchard, EA | 1 |
4 other study(ies) available for resveratrol and Constriction, Pathologic
| Article | Year |
|---|---|
Synthesis and evaluation of resveratrol derivatives as fetal hemoglobin inducers.
Topics: Analgesics; Animals; Cells, Cultured; Constriction, Pathologic; Disease Models, Animal; Humans; Interleukin-1beta; Lipopolysaccharides; Macrophages; Male; Mice; Nitric Oxide; Resveratrol; Structure-Activity Relationship; Tumor Necrosis Factor-alpha | 2020 |
The effects of resveratrol on chronic constriction injury of sciatic nerve in rats.
Topics: Animals; Antioxidants; Chronic Disease; Constriction, Pathologic; Immunohistochemistry; Insulin-Like Growth Factor I; Male; Motor Activity; Neuroprotective Agents; Peripheral Nerve Injuries; Rats, Wistar; Resveratrol; Sciatic Nerve; Stilbenes | 2014 |
Chronic resveratrol treatment exerts antihyperalgesic effect and corrects co-morbid depressive like behaviors in mice with mononeuropathy: involvement of serotonergic system.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antidepressive Agents; Brain; Comorbidity; Constriction, Pathologic; Depression; Disease Models, Animal; Hot Temperature; Hyperalgesia; Male; Mice, Inbred C57BL; Neuralgia; Receptor, Serotonin, 5-HT1A; Receptors, Serotonin; Resveratrol; Sciatic Neuropathy; Spinal Cord; Stilbenes; Touch | 2014 |
Novel nanocomposite stent coating releasing resveratrol and quercetin reduces neointimal hyperplasia and promotes re-endothelialization.
Topics: Angioplasty; Animals; Antimitotic Agents; Cell Proliferation; Constriction, Pathologic; Drug-Eluting Stents; Endothelium, Vascular; Female; Hyperplasia; Male; Nanocomposites; Neointima; Quercetin; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes | 2012 |